A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...
The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results